[177Lu]Lu-PSMA-617 compared with cabazitaxel in men with metastatic castration-resistant prostate cancer led to a higher PSA response and fewer grade 3 or 4 adverse events. [177Lu]Lu-PSMA-617 is a new effective class of therapy and a potential alternative to cabazitaxel.
During pregnancy or the first year after giving birth, depression affects 1 in 5 individuals worldwide.1,2 In addition to individual suffering and a high risk…
Both the MCPAP for Moms and PRISM interventions were equally effective in improving depression symptoms. This finding is important because the 4-point decrease in EPDS…
Maternal MHrH is a modifiable risk factor that explained a low to moderate risk of adverse birth outcomes in the Northern Territory. The knowledge highlights…
Home to about 8·2% of the global population, Latin America experienced a disproportionate burden of COVID-19. The region reported 80 million COVID-19 cases and 1·7…
In the first 2 years of implementation of RTS,S, the three primary doses were effectively deployed through national immunisation programmes. There was no evidence of…
The exposure of residents to lead in drinking water caused a national outcry, prompting requirements to update infrastructure and tighten water quality standards. Susan Jaffe…
Civil society has been limited by President Alexander Lukashenko, leaving few organisations to provide health care for migrants at the Belarus–EU border. Ed Holt reports.
The Global Burden of Disease assessment estimates that 20% of global type 2 diabetes cases are related to chronic exposure to particulate matter (PM) with…
In this prespecified pooled analysis of the STEP-HFpEF and STEP-HFpEF DM trials, semaglutide was superior to placebo in improving heart failure-related symptoms and physical limitations,…
Moderna’s decision has been criticised by the Africa CDC, with experts urging countries to invest domestically. Paul Adepoju reports.
